These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31377983)

  • 1. Upregulated Expression of CUX1 Correlates with Poor Prognosis in Glioma Patients: a Bioinformatic Analysis.
    Wu X; Feng F; Yang C; Zhang M; Cheng Y; Zhao Y; Wang Y; Che F; Zhang J; Heng X
    J Mol Neurosci; 2019 Dec; 69(4):527-537. PubMed ID: 31377983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpressed P75CUX1 promotes EMT in glioma infiltration by activating β-catenin.
    Xu A; Wang X; Luo J; Zhou M; Yi R; Huang T; Lin J; Wu Z; Xie C; Ding S; Zeng Y; Song Y
    Cell Death Dis; 2021 Feb; 12(2):157. PubMed ID: 33542188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
    Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
    Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional expression of ZICs as an independent indicator of survival in gliomas.
    Han Z; Jia J; Lv Y; Wang R; Cao K
    Sci Rep; 2021 Sep; 11(1):17532. PubMed ID: 34475426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TUBA1C expression promotes proliferation by regulating the cell cycle and indicates poor prognosis in glioma.
    Gui S; Chen P; Liu Y; Chen Q; Cheng T; Lv S; Zhou T; Song Z; Xiao J; He W; Yuan S; Cheng Z
    Biochem Biophys Res Commun; 2021 Nov; 577():130-138. PubMed ID: 34517210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
    Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
    Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
    Wang Y; Zhao W; Liu X; Guan G; Zhuang M
    J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas.
    Han MZ; Huang B; Chen AJ; Zhang X; Xu R; Wang J; Li XG
    Oncol Rep; 2017 Feb; 37(2):903-912. PubMed ID: 28075478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of SALL4 in patients with gliomas: high level of SALL4 expression is correlated with poor outcome.
    Zhang L; Yan Y; Jiang Y; Cui Y; Zou Y; Qian J; Luo C; Lu Y; Wu X
    J Neurooncol; 2015 Jan; 121(2):261-8. PubMed ID: 25359397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients.
    Liu Z; Shen F; Wang H; Li A; Wang J; Du L; Liu B; Zhang B; Lian X; Pang B; Liu L; Gao Y
    Cell Cycle; 2020 Jul; 19(13):1632-1640. PubMed ID: 32436804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
    Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
    Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.
    Kaur S; Ramdzan ZM; Guiot MC; Li L; Leduy L; Ramotar D; Sabri S; Abdulkarim B; Nepveu A
    Neuro Oncol; 2018 Mar; 20(4):484-493. PubMed ID: 29036362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell division cycle associated 7 like predicts unfavorable prognosis and promotes invasion in glioma.
    Shen FZ; Li XS; Ma JW; Wang XY; Zhao SP; Meng L; Liang SF; Zhao XL
    Pathol Res Pract; 2019 Jan; 215(1):50-56. PubMed ID: 30389317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of transcriptional coactivator TAZ in gliomas.
    Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
    Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CUX1 Facilitates the Development of Oncogenic Properties
    Feng F; Zhao Z; Zhou Y; Cheng Y; Wu X; Heng X
    Front Mol Biosci; 2021; 8():705008. PubMed ID: 34422906
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.
    Li H; Yang F; Hu A; Wang X; Fang E; Chen Y; Li D; Song H; Wang J; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
    EMBO Mol Med; 2019 Dec; 11(12):e10835. PubMed ID: 31709724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of the 58-kD microspherule protein (MSP58) is correlated with poor prognosis in glioma patients.
    Lin W; Li XM; Zhang J; Huang Y; Wang J; Zhang J; Jiang XF; Fei Z
    Med Oncol; 2013 Dec; 30(4):677. PubMed ID: 23996240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High TRAF3IP3 Level Predicts Poor Prognosis of Patients with Gliomas.
    Yang G; Tang S; Zhang J; Qin L
    World Neurosurg; 2021 Apr; 148():e436-e449. PubMed ID: 33444836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.